BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 16563702)

  • 1. Response to Kujawa et al. letter-to-the-editor.
    Sethuraman G; Taylor CC; Enerson M; Dunayevich E
    Schizophr Res; 2006 May; 84(1):172-3. PubMed ID: 16563702
    [No Abstract]   [Full Text] [Related]  

  • 2. [Letter to the editor].
    Román González N; Quintana Holgado A; Himénez Hernández MP
    Farm Hosp; 2013; 37(1):75-6. PubMed ID: 23461505
    [No Abstract]   [Full Text] [Related]  

  • 3. Should the CATIE study be a wake-up call?
    Ragins M
    Psychiatr Serv; 2005 Dec; 56(12):1489. PubMed ID: 16339608
    [No Abstract]   [Full Text] [Related]  

  • 4. Response to Shen J, Kobak K, Zhao Y, et al. Use of remote centralized raters via live 2-way video ina multicenter clinical trial for schizophrenia. (J Clin Psychopharmacol. 2008;28:691-693).
    Grunze HC; Höschl C; Montgomery SA; Sartorius N; Vieta E
    J Clin Psychopharmacol; 2009 Aug; 29(4):409; author reply 409-10. PubMed ID: 19593194
    [No Abstract]   [Full Text] [Related]  

  • 5. Definitions of response and remission in schizophrenia: recommendations for their use and their presentation.
    Leucht S; Davis JM; Engel RR; Kissling W; Kane JM
    Acta Psychiatr Scand Suppl; 2009; (438):7-14. PubMed ID: 19132961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The evaluation of long-term treatment with antipsychotics].
    Millet B
    Encephale; 2006 Dec; 32 Pt 3():S1072-5. PubMed ID: 17356502
    [No Abstract]   [Full Text] [Related]  

  • 7. A critical analysis and discussion of the appropriateness of the schizophrenia consensus remission criteria in clinical pharmaceutical trials.
    Schennach-Wolff R; Möller HJ; Jäger M; Seemüller F; Obermeier M; Messer T; Laux G; Pfeiffer H; Naber D; Schmidt LG; Gaebel W; Klosterkötter J; Heuser I; Maier W; Lemke MR; Rüther E; Klingberg S; Gastpar M; Riedel M
    Pharmacopsychiatry; 2010 Nov; 43(7):245-51. PubMed ID: 20927697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Schizophrenia: recent advances in psychopharmacology.
    Sharma T
    Br J Hosp Med; 1996 Feb 21-Mar 5; 55(4):194-8. PubMed ID: 8777500
    [No Abstract]   [Full Text] [Related]  

  • 9. [Maintenance pharmacotherapy of schizophrenia: remission and the effectiveness of long-acting risperidone therapy].
    Sárosi A
    Neuropsychopharmacol Hung; 2006 Dec; 8(4):179-87. PubMed ID: 17211053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myth and reality of pragmatic trials.
    Mohr P; Bitter I; Constant E; Jakovljević M; Jarema M; Pecenak J; Seifritz E; Svestka J; Sartorius N
    Psychiatr Danub; 2010 Mar; 22(1):2-3. PubMed ID: 20305584
    [No Abstract]   [Full Text] [Related]  

  • 11. Study shows newer schizophrenia treatments no more effective than old.
    Frantz S
    Nat Rev Drug Discov; 2005 Nov; 4(11):872-3. PubMed ID: 16299914
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparing symptom response among antipsychotic medications in CATIE.
    Levine SZ; Rabinowitz J; Ascher-Svanum H; Faries DE; Lawson AH
    J Clin Psychopharmacol; 2013 Feb; 33(1):123-6. PubMed ID: 23288232
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparative remission rates of schizophrenic patients using various remission criteria.
    Beitinger R; Lin J; Kissling W; Leucht S
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Oct; 32(7):1643-51. PubMed ID: 18616969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measuring remission in schizophrenia: response to Sethuraman et al., 2005.
    Kujawa M; Bossie CA; Lasser RA
    Schizophr Res; 2006 Mar; 83(1):109-10. PubMed ID: 16423505
    [No Abstract]   [Full Text] [Related]  

  • 15. First-episode psychosis in a managed care setting: clinical management and research.
    Jarskog LF; Mattioli MA; Perkins DO; Lieberman JA
    Am J Psychiatry; 2000 Jun; 157(6):878-84. PubMed ID: 10831465
    [No Abstract]   [Full Text] [Related]  

  • 16. Antipsychotic effects of AL 1965.
    Sathananthan G; Mir P; Gershon S
    Curr Ther Res Clin Exp; 1976 May; 19(5):516-9. PubMed ID: 7435
    [No Abstract]   [Full Text] [Related]  

  • 17. First-episode schizophrenia. Early intervention and medication discontinuation in the context of course and treatment.
    Wyatt RJ; Damiani LM; Henter ID
    Br J Psychiatry Suppl; 1998; 172(33):77-83. PubMed ID: 9764131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors which can make patients difficult to treat.
    Kane JM
    Br J Psychiatry Suppl; 1996 Dec; (31):10-4. PubMed ID: 8968650
    [No Abstract]   [Full Text] [Related]  

  • 19. Dose selection and comparator drugs in schizophrenia research.
    Kane JM
    J Clin Psychiatry; 2001; 62 Suppl 9():29-32; discussion 33-4. PubMed ID: 11379828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iloperidone for the management of adults with schizophrenia.
    Crabtree BL; Montgomery J
    Clin Ther; 2011 Mar; 33(3):330-45. PubMed ID: 21600386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.